相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann et al.
ANNALS OF INTERNAL MEDICINE (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
Plasminogen improves lung lesions and hypoxemia in patients with COVID-19
Y. Wu et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2020)
Pandemic COVID-19 Joins History's Pandemic Legion
David M. Morens et al.
MBIO (2020)
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
Franklin L. Wright et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series
Janice Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Mauro Panigada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Heparin resistance in COVID-19 patients in the intensive care unit
D. White et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Rescue therapy for severe COVID-19-associated acute respiratory distress syndrome with tissue plasminogen activator: A case series
Christopher D. Barrett et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation and management of shock in patients with COVID-19
Steven Fox et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2020)
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany
Carolin Edler et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2020)
Fibrinolysis and COVID-19: A plasmin paradox
Robert L. Medcalf et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Christophe Nougier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study
Maurizio Viecca et al.
PHARMACOLOGICAL RESEARCH (2020)
Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit
Annalisa Boscolo et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study
Felix Carl Fabian Schmitt et al.
ANNALS OF INTENSIVE CARE (2019)
Platelet HIF-2α promotes thrombogenicity through PAI-1 synthesis and extracellular vesicle release
Susheel N. Chaurasia et al.
HAEMATOLOGICA (2019)
THROMBIN PROVOKES DEGRANULATION OF PLATELET α-GRANULES LEADING TO THE RELEASE OF ACTIVE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
Benjamin R. Huebner et al.
SHOCK (2018)
Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism
William B. Stubblefield et al.
PLOS ONE (2016)
Clinical Significance of Intra-alveolar Fibrin Deposition in Transbronchial Lung Biopsy in Patients with Organizing Pneumonia
Nobuhiko Nagata et al.
LUNG (2015)
Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography
Mauro Panigada et al.
PLOS ONE (2015)
Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?
Patrick Paulus et al.
BIOMARKERS (2011)
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Mirjam E. Meltzer et al.
BLOOD (2010)
Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable, fibrinolysis inhibitor and factor XIII
Vance G. Nielsen et al.
BLOOD COAGULATION & FIBRINOLYSIS (2008)
The plasminogen activation system in lung disease
T. H. Sisson et al.
CURRENT DRUG TARGETS (2007)
SAPS 3 - From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission
RP Moreno et al.
INTENSIVE CARE MEDICINE (2005)
Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation
RT Schermuly et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2001)
分享论文
